Evidence map›Paper›PMID 28880900›Full record

ArticlePloS one2017

Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.

Giuseppe Maulucci, Ermanno Cordelli, Alessandro Rizzi, Francesca De Leva, Massimiliano Papi, Gabriele Ciasca, Daniela Samengo, Giovambattista Pani, Dario Pitocco, Paolo Soda and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Pathophysiology of Red Blood Cell Dysfunction in Diabetes and Its Complications.Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Giuseppe MaulucciIstituto di Fisica, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID http://orcid.org/0000-0002-2154-319X
Ermanno CordelliUnità di Sistemi di elaborazione e bioinformatica, Facoltà dipartimentale di Ingegneria, Università Campus Bio-Medico, Rome, Italy.
Alessandro RizziIstituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.
Francesca De LevaIstituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.
Massimiliano PapiIstituto di Fisica, Università Cattolica del Sacro Cuore, Rome, Italy.
Gabriele CiascaIstituto di Fisica, Università Cattolica del Sacro Cuore, Rome, Italy.
Daniela SamengoIstituto di Patologia, Università Cattolica del Sacro Cuore Rome, Italy.
Giovambattista PaniIstituto di Patologia, Università Cattolica del Sacro Cuore Rome, Italy.
Dario PitoccoIstituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.
Paolo SodaUnità di Sistemi di elaborazione e bioinformatica, Facoltà dipartimentale di Ingegneria, Università Campus Bio-Medico, Rome, Italy.
Giovanni GhirlandaIstituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.
Giulio IannelloUnità di Sistemi di elaborazione e bioinformatica, Facoltà dipartimentale di Ingegneria, Università Campus Bio-Medico, Rome, Italy.
Marco De SpiritoIstituto di Fisica, Università Cattolica del Sacro Cuore, Rome, Italy.
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · ITUniversità Campus Bio-Medico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylation, oxidation and other post-translational modifications of membrane and transmembrane proteins can alter lipid density, packing and interactions, and are considered an important factor that affects fluidity variation in membranes. Red blood cells (RBC) membrane physical state, showing pronounced alterations in Type 1 diabetes mellitus (T1DM), could be the ideal candidate for monitoring the disease progression and the effects of therapies. On these grounds, the measurement of RBC membrane fluidity alterations can furnish a more sensitive index in T1DM diagnosis and disease progression than Glycosylated hemoglobin (HbA1c), which reflects only the information related to glycosylation processes. Here, through a functional two-photon microscopy approach we retrieved fluidity maps at submicrometric scale in RBC of T1DM patients with and without complications, detecting an altered membrane equilibrium. We found that a phase separation between fluid and rigid domains occurs, triggered by systemic effects on membranes fluidity of glycation and oxidation. The phase separation patterns are different among healthy, T1DM and T1DM with complications patients. Blood cholesterol and LDL content are positively correlated with the extent of the phase separation patterns. To quantify this extent a machine learning approach is employed to develop a Decision-Support-System (DSS) able to recognize different fluidity patterns in RBC. Preliminary analysis shows significant differences(p<0.001) among healthy, T1DM and T1DM with complications patients. The development of an assay based on Phase separation of the plasma membrane of the Red Blood cells is a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus, and could allow customization and the selection of medical treatments in T1DM in clinical settings, and enable the early detection of complications.

Indexed as

Diagnostic Techniques and ProceduresDisease ProgressionCholesterolDecision Support Systems, ClinicalDiabetes Mellitus, Type 1Erythrocyte MembraneGlycated HemoglobinGlycosylationHumansInsulinLipoproteins, LDLMembrane FluidityMembrane MicrodomainsOxidation-ReductionCholesterolGlycated HemoglobinInsulinLipoproteins, LDL

Identifiers

PMID28880900
PMCPMC5589169
OpenAlexW2751444860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.